Non-invasive combination therapy of IPL and RF in acne inversa (NICE)

Non-invasive combination therapy of IPL and RF in acne inversa (NICE) - NICE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00014017

Enrollment

Registered

2018-02-13

Start date

2014-07-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne inversa L73.2

Interventions

Group 1: Group 1: Observation for 12 weeks, treatment with IPL and RF for 24 weeks. Group 2: Group 2: Observation for 12 weeks, treatment with IPL for 12 weeks, thereafter cross-over and treatment wit

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Acne inversa since longer than 6 months before study - at least 3 clinically visible abscesses or noduli - informed consent for study participation

Exclusion criteria

Exclusion criteria: - Malignant Tumors - concomitant systemic or topical treatment with immunomodulatory agents, antibiotics, retinoids, etc. /exceptions: transient acute treatment due to acute abscess, local antiseptics, local adminitration of ichthyol - pregnancy

Design outcomes

Primary

Measure	Time frame
Change in active lesion count assessed after observation period (12 weeks), then again after 12 weeks for treatment and after 24 weeks of treatment	—

Secondary

Measure	Time frame
Change in DLQI assessed after observation period (12 weeks), then again after 12 weeks for treatment and after 24 weeks of treatment	—

Countries

Germany

Contacts

Public ContactSophia Wilden

Klinik für Dermatologie, Universitätsmedizin Mainz

sophia.wilden@unimedizin-mainz.de+49-6131-170

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026